BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11422030)

  • 1. Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis.
    Köse K; Utaş S; Yazici C; Akdaş A; Keleştimur F
    Br J Dermatol; 2001 Jun; 144(6):1121-6. PubMed ID: 11422030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant potential of propylthiouracil in patients with psoriasis.
    Utaş S; Köse K; Yazici C; Akdaş A; Keleştimur F
    Clin Biochem; 2002 May; 35(3):241-6. PubMed ID: 12074833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propylthiouracil in psoriasis: results of an open trial.
    Elias AN; Goodman MM; Liem WH; Barr RJ
    J Am Acad Dermatol; 1993 Jul; 29(1):78-81. PubMed ID: 8315081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid vascular conductance: differential effects of elevated plasma thyrotropin (TSH) induced by treatment with thioamides or TSH-releasing hormone.
    Connors JM; Huffman LJ; Michalkiewicz M; Chang BS; Dey RD; Hedge GA
    Endocrinology; 1991 Jul; 129(1):117-25. PubMed ID: 1905224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy and safety of propylthiouracil in psoriasis: an open-label study.
    Gnanaraj P; Malligarjunan H; Dayalan H; Karthikeyan S; Narasimhan M
    Indian J Dermatol Venereol Leprol; 2011; 77(6):673-6. PubMed ID: 22016273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propylthiouracil (PTU) pharmacology in the rat. II. Effects of PTU on thyroid function.
    Cooper DS; Kieffer JD; Halpern R; Saxe V; Mover H; Maloof F; Ridgway EC
    Endocrinology; 1983 Sep; 113(3):921-8. PubMed ID: 6872961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
    Abuid J; Larsen PR
    J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil.
    Israel Y; Walfish PG; Orrego H; Blake J; Kalant H
    Gastroenterology; 1979 Jan; 76(1):116-22. PubMed ID: 758132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithyroid effects of propylthiouracil and sulfamonomethoxine in rats and monkeys.
    Takayama S; Aihara K; Onodera T; Akimoto T
    Toxicol Appl Pharmacol; 1986 Feb; 82(2):191-9. PubMed ID: 2418534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide.
    Kasai K; Suzuki H; Kikuchi T; Ieiri T; Takemura Y
    Endocrinol Jpn; 1976 Aug; 23(4):347-54. PubMed ID: 1024041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of PTU on IL-12 and IL-10 in psoriasis.
    Elias AN; Nanda VS; Barr RJ
    J Drugs Dermatol; 2003 Dec; 2(6):645-8. PubMed ID: 14711144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gap-junctional-intercellular communication in thyroid-follicular cells by propylthiouracil and low iodine diet.
    Kolaja KL; Petrick JS; Klaassen CD
    Toxicology; 2000 Feb; 143(2):195-202. PubMed ID: 10755705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureylene.
    Elias AN; Nanda VS; Barr RJ
    BMC Dermatol; 2003 Jul; 3():3. PubMed ID: 12841851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of triiodothyronine to prevent propylthiouracil-induced hypothyroidism and goiter in fetal sheep.
    Horger EO; Kenimer JG; Azukizawa M; Hershman JM; Kansal PC; Leaming AB
    Obstet Gynecol; 1976 Jan; 47(1):46-9. PubMed ID: 1246393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of topical propylthiouracil in the treatment of patients with psoriasis.
    Elias AN; Dangaran K; Barr RJ; Rohan MK; Goodman MM
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):455-8. PubMed ID: 8077472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of involucrin in psoriatic lesions following therapy with propylthiouracil, an anti-thyroid thioureylene: immunohistochemistry and gene expression analysis.
    Gnanaraj P; Dayalan H; Elango T; Malligarjunan H; Raghavan V; Rao R
    Int J Dermatol; 2015 Mar; 54(3):302-6. PubMed ID: 25267471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study.
    Bukulmez G; Akan T; Ciliv G
    Eur J Dermatol; 2000 Jun; 10(4):274-6. PubMed ID: 10846253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in thyroid function caused by continuous treatment with thiouracil in rats].
    Recio P; de la Cruz LF; Illera M
    Rev Esp Fisiol; 1986 Dec; 42(4):513-6. PubMed ID: 3563076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of propylthiouracyl-induced low thyroid function on secretion response and action of insulin in sheep.
    Achmadi J; Terashima Y
    Domest Anim Endocrinol; 1995 Apr; 12(2):157-66. PubMed ID: 7600766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral propylthiouracil for the treatment of resistant plaque psoriasis.
    Chowdhury MM; Marks R
    J Dermatolog Treat; 2001 Jun; 12(2):81-5. PubMed ID: 12243663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.